Study of the Prevalence of Iron Deficiency in Patients With Heart Failure (CARENFER IC)

Vifor

Status: Unknown

Conditions: Heart Failure

Treatments: Diagnostic Test: Iron status testing

Study type: Interventional

Funder types: Industry

Identifiers

NCT03924258

CARENFER IC

Details and patient eligibility

About

Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub (unpublished) on the French national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is recommended for patients with Heart Failure (French Health High Authority 2011). The purpose of this study is to obtain current data on the prevalence of iron deficiency in France in patients with Heart Failure, applying the recommendations of European Society of Cardiology and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).

Enrollment: 1,300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient, male or female, over 18 years of age
• Patient present at the hospital on the day of the study
• Diagnosis of Heart Failure (acute or chronic) regardless of left ventricular ejection fraction (LVEF)
• Patient with signed consent

Exclusion criteria

• Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
• Pregnant or breastfeeding woman

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,300 participants in 1 patient group

HEART FAILURE

Experimental group

Description:

Patients with Heart Failure diagnosis

Treatment:

Diagnostic Test: Iron status testing